Author name: Vincent Racaniello

I'm Professor of Microbiology and Immunology at Columbia University in New York. I run a research lab where we study poliovirus, rhinovirus, and other RNA viruses. I also love teaching about viruses - check out virology.ws, microbe.tv, or iTunes University for some of my offerings. I want to be Earth's virology professor.

Raltegravir inhibits murine leukemia virus: implications for chronic fatigue syndrome?

27 Comments / Basic virology, Information / By

The finding that a retrovirus, XMRV, is associated with chronic fatigue syndrome has lead to the suggestion that the disease might be treated with some of the antiviral drugs used to treat AIDS. The integrase inhibitor Raltegravir has been found to block the replication of murine leukemia virus, which is highly related to XMRV. But …

Raltegravir inhibits murine leukemia virus: implications for chronic fatigue syndrome? Read More »

Novartis influenza A H1N1 vaccine clinical data

10 Comments / Information / By

Although the influenza 2009 H1N1 vaccine produced by Novartis, Fluvirin, was previously approved for use in the US, the clinical data supporting its safety and immunogenicity had not been released. The company has now issued a media release containing interim clinical data on the effects of the vaccine in humans. According to the company, testing …

Novartis influenza A H1N1 vaccine clinical data Read More »

Viruses and journalism: Off-the-shelf chemicals

2 Comments / Commentary, Information / By

I have had many opportunities to speak with journalists of different kinds during the more than 30 years that I have studied viruses. I wrote previously about my negative experience with CNN. I’d like to relate a much more positive encounter with newspaper reporters. As a postdoctoral fellow in David Baltimore’s laboratory I was fortunate …

Viruses and journalism: Off-the-shelf chemicals Read More »

Tamiflu-resistant pandemic influenza H1N1 virus selected by prophylaxis

6 Comments / Basic virology, Information / By

The emergence of oseltamivir (Tamiflu)-resistant 2009 H1N1 influenza virus in a Canadian family illustrates the basic concept that viral loads depend on the dose of antiviral drug. Neuraminidase inhibitors like Tamiflu and Relenza are used to treat severe illness caused by the 2009 pandemic influenza A (H1N1) virus. The antiviral drugs may also be used …

Tamiflu-resistant pandemic influenza H1N1 virus selected by prophylaxis Read More »

Scroll to Top